Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii

Authors: Huiping Huang, Borong Chen, Gang Liu, Jing Ran, Xianyu Lian, Xinhua Huang, Nan Wang, Zhengjie Huang

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Acinetobacter baumannii (AB) is critical for healthcare-associated infections (HAI) with significant regional differences in the resistance rate, but its risk factors and infection trends has not been well studied. We aimed to explore the risk factors, epidemiological characteristics and resistance of multidrug-resistant Acinetobacter baumannii (MDR-AB) in intensive care unit inpatients.

Methods

Data of patients with MDR-AB (195 cases), and with antibiotic-sensitive AB infection (294 cases, control) during January to December, 2015 in three medical centers in Xiamen, China were conducted and analyzed in the present retrospective study.

Results

Lower respiratory tract infection with AB accounted for 68.71%. MDR-AB was detected in 39.88% of all cases. Univariate analysis suggested that mechanical ventilation, indwelling catheter, cancer patients, length of hospitalization in intensive care unit (ICU) ≥15 d, Acute Physiology and Chronic Health Evaluation (APACHE) II score, combined using antibiotic before isolation of AB and use of third-lines cephalosporins were associated with the development of MDR-AB healthcare-associated infections. Dose-response relationship analysis suggested that the age and the days of mechanical ventilation were associated with increased infection with MDR-AB. Logistic regression analysis suggested that, mechanical ventilation, combined using antibiotic before isolation of AB, and indwelling catheter, were associated with MDR-AB infection, with odds ratios (OR) and 95% confidence intervals (CI) of 3.93 (1.52–10.14), 4.11 (1.58–10.73), and 4.15 (1.32–12.99), respectively.

Conclusions

MDR-AB infection was associated with mechanical ventilation, combined using antibiotic before isolation of AB, and indwelling catheter. Furthermore, the age and the days of mechanical ventilation were associated with increased infection with MDR-AB.
Literature
1.
go back to reference Fu Q, Ye H, Liu S. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii. Am J Infect Control. 2015;43(8):857–60.CrossRefPubMed Fu Q, Ye H, Liu S. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii. Am J Infect Control. 2015;43(8):857–60.CrossRefPubMed
2.
go back to reference Chaisathaphol T, Chayakulkeeree M. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital. J Med Assoc Thail. 2014;97(Suppl 3):S35–45. Chaisathaphol T, Chayakulkeeree M. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital. J Med Assoc Thail. 2014;97(Suppl 3):S35–45.
3.
go back to reference Behnia M, et al. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res Notes. 2014;7:232.CrossRefPubMedPubMedCentral Behnia M, et al. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res Notes. 2014;7:232.CrossRefPubMedPubMedCentral
4.
go back to reference Medell M, et al. Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance. MEDICC Rev. 2013;15(2):26–9.PubMed Medell M, et al. Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance. MEDICC Rev. 2013;15(2):26–9.PubMed
6.
go back to reference Werarak P, et al. Acinetobacter baumannii nosocomial pneumonia in tertiary care hospitals in Thailand. J Med Assoc Thail. 2012;95(Suppl 2):S23–33. Werarak P, et al. Acinetobacter baumannii nosocomial pneumonia in tertiary care hospitals in Thailand. J Med Assoc Thail. 2012;95(Suppl 2):S23–33.
7.
go back to reference Gurung M, et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2013;19:219–22.CrossRefPubMed Gurung M, et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2013;19:219–22.CrossRefPubMed
8.
go back to reference Garlantezec R, et al. Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. J Hosp Infect. 2011;77(2):174–5.CrossRefPubMed Garlantezec R, et al. Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. J Hosp Infect. 2011;77(2):174–5.CrossRefPubMed
9.
go back to reference Zarrilli R, et al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect. 2012;82(4):260–5.CrossRefPubMed Zarrilli R, et al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect. 2012;82(4):260–5.CrossRefPubMed
10.
go back to reference Agodi A, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86(4):260–6.CrossRefPubMed Agodi A, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86(4):260–6.CrossRefPubMed
11.
go back to reference Ayraud-Thevenot S, et al. Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect. 2012;82(4):290–2.CrossRefPubMed Ayraud-Thevenot S, et al. Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect. 2012;82(4):290–2.CrossRefPubMed
12.
go back to reference Zarrilli R, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–9.CrossRefPubMed Zarrilli R, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–9.CrossRefPubMed
13.
go back to reference Taitt CR, et al. Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother. 2014;58(2):767–81.CrossRefPubMedPubMedCentral Taitt CR, et al. Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother. 2014;58(2):767–81.CrossRefPubMedPubMedCentral
14.
go back to reference Institute, C.a.L.S. Methods for dilution antimicrobial susceptiblity tests for bacteria that grow aerobically;approved standard-eighth edition. Clinical and Laboratory Standards Institute. 2008;29(2):11. Institute, C.a.L.S. Methods for dilution antimicrobial susceptiblity tests for bacteria that grow aerobically;approved standard-eighth edition. Clinical and Laboratory Standards Institute. 2008;29(2):11.
15.
go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.CrossRefPubMed Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.CrossRefPubMed
16.
go back to reference Zorgani A, et al. Prevalence of device-associated Nosocomial infections caused by gram-negative bacteria in a trauma intensive care unit in Libya. Oman Med J. 2015;30(4):270–5.CrossRefPubMedPubMedCentral Zorgani A, et al. Prevalence of device-associated Nosocomial infections caused by gram-negative bacteria in a trauma intensive care unit in Libya. Oman Med J. 2015;30(4):270–5.CrossRefPubMedPubMedCentral
17.
go back to reference Dejsirilert S, et al. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. J Med Assoc Thail. 2009;92(Suppl 4):S34–45. Dejsirilert S, et al. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. J Med Assoc Thail. 2009;92(Suppl 4):S34–45.
19.
go back to reference Koo SH, et al. Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J Lab Med. 2010;30(5):498–506.CrossRefPubMed Koo SH, et al. Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J Lab Med. 2010;30(5):498–506.CrossRefPubMed
20.
go back to reference Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis. 2014;59(Suppl 5):S335–9.CrossRefPubMedPubMedCentral Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis. 2014;59(Suppl 5):S335–9.CrossRefPubMedPubMedCentral
21.
go back to reference Vasudevan A, et al. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients). Prev Med. 2013;57(Suppl):S70–3.CrossRefPubMed Vasudevan A, et al. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients). Prev Med. 2013;57(Suppl):S70–3.CrossRefPubMed
22.
go back to reference Jung JY, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010;10:228.CrossRefPubMedPubMedCentral Jung JY, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010;10:228.CrossRefPubMedPubMedCentral
23.
go back to reference Zheng YL, et al. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am J Infect Control. 2013;41(7):e59–63.CrossRefPubMed Zheng YL, et al. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am J Infect Control. 2013;41(7):e59–63.CrossRefPubMed
24.
go back to reference McCracken M, et al. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis. 2011;69(3):335–41.CrossRefPubMed McCracken M, et al. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis. 2011;69(3):335–41.CrossRefPubMed
25.
Metadata
Title
A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii
Authors
Huiping Huang
Borong Chen
Gang Liu
Jing Ran
Xianyu Lian
Xinhua Huang
Nan Wang
Zhengjie Huang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2932-5

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.